More direct evidence for a role for IGFs in the development of cancer was provided in 1998 when Hankinson et al. reported that the risk of breast cancer was associated with the levels of circulating IGF-1 and IGFBP-3 [189]. This evidence concerns the gene IGF1 and breast cancer.